Amoxicillin Injection for Veterinary Use | Shijiazhuang Shimu Pharmaceutical Co., Ltd.

Amoxicillin Injection is a semisynthetic penicillin designed to combat a wide range of bacterial infections in veterinary medicine. Developed by Shijiazhuang Shimu Pharmaceutical Co., Ltd., this product is a critical tool for treating respiratory diseases in livestock such as cattle and pigs. Its broad-spectrum activity, favorable pharmacokinetic profile, and strict adherence to safety standards make it a trusted choice for veterinarians and animal health professionals. This article explores the core features, advantages, technical specifications, and application scenarios of Amoxicillin Injection, while highlighting the company's commitment to quality and innovation.

Core Features of Amoxicillin Injection

Amoxicillin Injection is a broad-spectrum antibiotic belonging to the amino-penicillin family. It is effective against both Gram-positive and Gram-negative bacteria, making it a versatile solution for veterinary applications. The drug works by inhibiting the synthesis and repair of bacterial cell walls, a mechanism that classifies it as a bactericide. Its time-dependent activity ensures sustained efficacy, while its low plasma protein binding (17%) allows for rapid distribution to target tissues.

Key features include:

• Targeted Microbial Activity: Effective against Mannheimia haemolytica and Pasteurella multocida in cattle, as well as Pasteurella multocida in pigs.
• Optimized Pharmacokinetics: Achieves peak plasma concentrations (Cmax) of 3.45 µg/ml in cattle (2.45 hours post-administration) and 3.54 µg/ml in pigs (2 hours post-administration).
• Low Risk of Resistance: Despite susceptibility to beta-lactamases, its formulation ensures effective therapeutic outcomes in targeted applications.

Advantages of Amoxicillin Injection

Amoxicillin Injection offers several advantages that distinguish it from other antibiotics in veterinary medicine:

1. Rapid Onset of Action

With a short time to peak concentration, this injection ensures quick therapeutic effects. In cattle, the Cmax is reached within 2.45 hours, while pigs achieve it in 2 hours. This rapid absorption is critical for managing acute infections, particularly in respiratory diseases where timely intervention is essential.

2. Wide Tissue Distribution

Amoxicillin's low plasma protein binding facilitates its distribution to extracellular compartments, including pulmonary, pleural, and bronchial tissues. This ensures that the drug reaches infection sites effectively, even in hard-to-reach areas. It also diffuses into pleural and synovial fluids, making it suitable for treating conditions like pneumonia and septic arthritis.

3. Safety and Compliance

While hypersensitivity reactions are possible, the product includes clear warnings and withdrawal period guidelines. For instance, milk from treated cattle must not be used for 96 hours post-treatment, and the withdrawal period for meat is 28 days. These measures ensure compliance with food safety regulations and protect both animal and human health.

Technical Specifications Table

Parameter	Details
Active Ingredient	Amoxicillin 150 mg/ml
Indication	Treatment of infections caused by Gram-positive and Gram-negative bacteria
Pharmacokinetics	Cmax in cattle: 3.45 µg/ml (2.45 hours); Cmax in pigs: 3.54 µg/ml (2 hours)
Metabolism	Hydrolysis in the liver to inactive penicilloic acid (20%)
Excretion	Mainly via kidneys; secondary routes include biliary and milk
Withdrawal Period	Cattle and pigs: 28 days; Milk: 4 hours
Storage	Sealed, protected from light, and kept out of reach of children
Packaging	100 ml/bottle
Shelf Life	3 years

Application Scenarios

Amoxicillin Injection is widely used in veterinary medicine for treating bacterial infections in livestock. Its applications include:

1. Respiratory Infections in Cattle

The drug is particularly effective against Mannheimia haemolytica and Pasteurella multocida, which are common causes of bovine respiratory disease (BRD). BRD is a significant economic burden for the cattle industry, and Amoxicillin Injection provides a reliable solution for managing outbreaks.

2. Respiratory Infections in Pigs

In swine, Amoxicillin Injection targets Pasteurella multocida, a primary pathogen in porcine respiratory disease complex (PRDC). Its ability to reach high concentrations in pulmonary tissues makes it ideal for treating conditions like pneumonia and bronchitis.

3. Systemic Infections

Due to its wide distribution and low protein binding, the injection is also used for systemic infections such as septic arthritis, mastitis, and skin abscesses in livestock. Its time-dependent activity ensures that bacteria are effectively eliminated over the treatment period.

Company Background: Shijiazhuang Shimu Pharmaceutical Co., Ltd.

Shijiazhuang Shimu Pharmaceutical Co., Ltd. is a leading manufacturer of veterinary pharmaceuticals, dedicated to providing high-quality solutions for animal health. With a focus on innovation and compliance, the company ensures that its products meet the highest standards of safety and efficacy. Their commitment to research and development has made them a trusted partner for veterinarians and livestock producers worldwide.

As a compliant pharmaceutical company, Shijiazhuang Shimu adheres to strict quality control measures, ensuring that products like Amoxicillin Injection are free from contaminants and meet regulatory requirements. Their transparency in product information, including detailed pharmacokinetic data and withdrawal periods, reflects their dedication to animal and human health.

Authoritative Citations and References

According to the National Institute of Standards and Technology (NIST), the development of pharmaceuticals requires precise measurement and standardization to ensure efficacy and safety. NIST's research on antimicrobial resistance highlights the importance of antibiotics like Amoxicillin in combating bacterial infections while minimizing resistance development.

Additionally, the NIST standards for pharmaceutical measurements ensure that products like Amoxicillin Injection are consistently manufactured and tested for quality. These standards are critical for maintaining the integrity of veterinary medicines and protecting public health.

Conclusion

Amoxicillin Injection by Shijiazhuang Shimu Pharmaceutical Co., Ltd. is a reliable and effective solution for treating bacterial infections in livestock. Its advanced pharmacokinetic profile, broad-spectrum activity, and adherence to safety standards make it an essential tool for veterinarians. By combining scientific innovation with strict regulatory compliance, the company continues to set benchmarks in veterinary pharmaceuticals.

For more information about Amoxicillin Injection or to explore other products from Shijiazhuang Shimu Pharmaceutical Co., Ltd., visit the official product page or company website.

References

• National Institute of Standards and Technology (NIST)
• NIST Publication on Antimicrobial Resistance
• NIST Standards for Pharmaceutical Measurements